LONG-TERM NON-INTERVENTIONAL SAFETY STUDY OF EMICIZUMAB TREATMENT IN PATIENTS WITH MODERATE HAEMOPHILIA A AND SEVERE BLEEDING PHENOTYPE (STUDY BO44691, PASS)

First published 13/06/2024

Last updated 12/05/2025

EU PAS number:

EUPAS1000000174

Study

Planned

Documents

Study protocol

Initial protocol

Prot BO44691 emicizumab v2, Published Output-1_Redacted.pdf

English (1.97 MB - PDF) View document

Updated protocol

Prot BO44691 emicizumab v3, Published Output_Redacted.pdf

First published: 07/05/2025

English (1.8 MB - PDF) View document

Study results

Study report

Other information

Secondary tabs